Hollings Cancer Center | Strategic Alliance Partners

Latest from Hollings Cancer Center

Dr. Carolyn Britten on Next Steps in Immunotherapy

September 15, 2015

Video

Carolyn D. Britten, MD, chief, Division of Hematology Oncology, associate director, Clinical Investigations, at the Hollings Cancer Center, Medical University of South Carolina, discusses questions that remain in immunotherapy.

Cancer Phase I Trials Expert Carolyn D. Britten, MD, Named Director of Hematology/Oncology Division for Medical University of South Carolina

July 07, 2015

Article

Britten continues as Associate Director for Clinical Investigations for the MUSC Hollings Cancer Center.

International Team Including Hollings Cancer Center Scientist Finds Genetic Variants Key in Understanding Origins of Ovarian Cancer

June 18, 2015

Article

International genome-Âwide association study (GWAS) also identifies key gene responsible for expressing subtype of ovarian cancer.

New Genomic Test Will Benefit Patients Being Screened for Lung Cancer

May 26, 2015

Article

New England Journal of Medicine Publishes Study Co-Led by Hollings Cancer Center Researcher Showing Potential of New Genomic Test In Lung Screening.

Hollings Cancer Center Researcher Receives Prestigious Governor's Award for Science

March 30, 2015

Article

Dr. Matthew J. Carpenter, an associate professor at the Medical University of South Carolina and researcher with the MUSC Hollings Cancer Center, is the recipient of the 2015 Governor's Young Scientist Award for Excellence in Scientific Research.

Helping Cancer Patients Quit Smoking Should Be a Standard of Care

March 30, 2015

Article

Most oncologists do not regularly provide evidence-based tobacco cessation support for patients with cancer who smoke. However, addressing tobacco use is not as difficult as some might think.